Evaluation of Platelet Parameters in Patients with Preeclampsia in Comparison with Healthy Pregnant Women Referring to Ganjavian Hospital in Dezful City in 2019
Trends in Medical Sciences · 2022
DOI: 10.5812/tms-121181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Medical Sciences, 2022. Verfasst von Fahimeh Papiahmadi und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Preeclampsia is one of the complications of pregnancy that endangers the life of the mother and the fetus. This complication accounts for 18% of maternal mortality and is the second leading cause of maternal mortality in Iran. Various studies have shown the important role of platelets in the pathogenesis of preeclampsia.
Objectives
This study was conducted to evaluate platelet parameters in patients with preeclampsia compared to healthy pregnant women who were referred to Ganjavian hospital in Dezful city in 2019.
Methods
In this study, which is a retrospective case-control study, the files of women who gave birth in Ganjavian hospital in 2019 were examined. The files of the case group, which included people with preeclampsia, were selected as available samples (104 people), and the control group, which included pregnant women without preeclampsia, were randomly selected using a table of random numbers (104 cases). Criteria for entering the study in the group with preeclampsia included BP ≥ 140/90 mmHg, proteinuria of more than 300 mg in 24-hour urine or 30 mg consistently in random urine samples, and gestational age over 20 weeks. Also, people with any underlying disease, such as diabetes, chronic hypertension, known platelet disorders, multiple birth, and drug use (heparin, aspirin) in the group with preeclampsia were excluded from the study. The data of this study were analyzed using SPSS software version 20, and independent t-test, and Mann-Whitney U test at a significant level lower than 0.05.
Results
There was no statistically significant difference in demographic factors between the two case and control groups. There was a statistically significant difference between the mean hemoglobin in healthy women 11.91 ± 1.30 and preeclampsia 10.89 ± 1.09 (P < 0.0001). Also, according to the findings, the individuals of the two groups had a significant difference in terms of mean platelet volume (MPV): Healthy women: 10.79 ± 1.24 and preeclampsia women: 12.98 ± 1.16 (P < 0.0001). Also, the results of the Mann-Whitney U test showed that there was a statistically significant difference between the number of platelets in healthy women (284.52 ± 60.58 mm3) and preeclampsia women (149.30 ± 30.38 mm3) (P < 0.0001).
Conclusions
Considering the importance of reducing the complications and mortality of pregnant mothers, early detection of changes in platelet factors during pregnancy can be a predictive factor in identifying people at risk for preeclampsia.
Zitieren
APA
Papiahmadi, F., Mirsamiyazdi, N., Amiri, R., Masoudiyekta, L., Bahrami, H., & Nosratabadi, M. (2022). Evaluation of Platelet Parameters in Patients with Preeclampsia in Comparison with Healthy Pregnant Women Referring to Ganjavian Hospital in Dezful City in 2019. Trends in Medical Sciences. https://doi.org/10.5812/tms-121181
Vancouver
Papiahmadi F, Mirsamiyazdi N, Amiri R, Masoudiyekta L, Bahrami H, Nosratabadi M. Evaluation of Platelet Parameters in Patients with Preeclampsia in Comparison with Healthy Pregnant Women Referring to Ganjavian Hospital in Dezful City in 2019. Trends in Medical Sciences. 2022. doi:10.5812/tms-121181
BibTeX
@article{Papiahmadi2022,
author = {Papiahmadi, Fahimeh and Mirsamiyazdi, Nastaran and Amiri, Radman and Masoudiyekta, Leila and Bahrami, Hadi and Nosratabadi, Mahnaz},
title = {Evaluation of Platelet Parameters in Patients with Preeclampsia in Comparison with Healthy Pregnant Women Referring to Ganjavian Hospital in Dezful City in 2019},
journal = {Trends in Medical Sciences},
year = {2022},
doi = {10.5812/tms-121181}
}
EUVIMED